InMode Ltd. (NASDAQ:INMD) Q2 2023 Earnings Conference Call July 27, 2023 8:30 AM ET

Company Participants

Miri Segal - Investor Relations, MS-IR LLC

Moshe Mizrahy - Chairman and CEO

Shakil Lakhani - President, North America

Yair Malca - Chief Financial Officer

Spero Theodorou - Chief Medical Officer

Conference Call Participants

Matt Miksic - Barclays

Caitlin Cronin - Canaccord Genuity

Jeff Johnson - Baird

Mike Matson - Needham & Company

Ryan Barokas - UBS

Operator

Good day, and welcome to the InMode Second Quarter 2023 Earnings Results Conference Call. All participants will be in listen-only mode. [Operator instructions] After today's presentation, there will be an opportunity to ask questions. [Operator instructions] Please note this event is being recorded.

I'd now like to turn the c call over to Miri Segal of MS-IR. Please go ahead.

Miri Segal

Thank you, operator and to everyone for joining us today. Welcome to InMode's second quarter 2023 earnings call. Before we begin, I would like to remind our listeners that certain information provided on this call may contain forward-looking statements, and the safe harbor statement outlined in today's earnings release also pertains to this call. If you have not received a copy of the release, please go to the Investor Relations section of the Company's website.

Changes in business, competitive, technological, regulatory and other factors could cause actual results to differ materially from those expressed by the forward-looking statements made today. Our historical results are not necessarily indicative of future performance. As such, we can give no assurance as to the accuracy of our forward-looking statements and assume no obligation to update them, except as required by law.

With that, I'd like to pass the call over to Moshe Mizrahy, Chairman and CEO. Moshe, please go ahead.

Moshe Mizrahy

Thank you, Miri and to everyone for joining us. With me today are Dr. Michael Kreindel, our Co-Founder and Chief Technology Officer; Yair Malca, our Chief Financial Officer; Shakil Lakhani, our President in North America; Dr. Spero Theodorou, our Chief Medical Officer; and Rafael Lickerman, our VP of Finance. Following our prepared remarks, we will be available to answer your question.

We're happy to report a record quarter on all fronts. We announced record revenue of $136.1 million, an increase of 20% compared to the second quarter of 2022. Sales from our platforms reached over 1,600 units, and the numbers of disposable sold totalled over 270,000, the most in our company history.